Related Experiment Video
Updated: Oct 19, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity
J Lisztwan1, G Imbert, C Wirbelauer
1Friedrich Miescher Institut, CH-4058 Basel, Switzerland.
Abstract:
pVHL, the product of the VHL tumor suppressor gene, plays an important role in the regulation of cell growth and differentiation of human kidney cells, and inactivation of the VHL gene is the most frequent genetic event in human kidney cancer. The biochemical function of pVHL is unknown. Here we report that pVHL exists in vivo in a complex that displays ubiquitination-promoting activity in conjunction with the universally required components E1, E2, and ubiquitin. pVHL-associated ubiquitination activity requires, at a minimum, pVHL to bind elongin C and Cul-2, relatives of core components of SCF (Skp1-Cdc53/Cul-1-F-box protein) E3 ligase complexes. Notably, certain tumor-derived mutants of pVHL demonstrate loss of associated ubiquitination promoting activity. These results identify pVHL as a component of a potential SCF-like E3 ubiquitin-protein ligase complex and suggest a direct link between pVHL tumor suppressor and the process of ubiquitination.
Insights
The VHL tumor suppressor protein (pVHL) is linked to kidney cancer. This study reveals pVHL
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- The VHL tumor suppressor gene product, pVHL, is crucial for regulating human kidney cell growth and differentiation.
- VHL gene inactivation is a frequent event in human kidney cancer, yet pVHL's biochemical function remains unclear.
Purpose of the Study:
- To elucidate the biochemical function of pVHL.
- To investigate the role of pVHL in ubiquitination and its potential link to kidney cancer.
Main Methods:
- In vivo complex analysis involving pVHL, E1, E2, and ubiquitin.
- Biochemical assays to assess ubiquitination-promoting activity.
- Analysis of tumor-derived pVHL mutants.
Main Results:
- pVHL forms a complex with E1, E2, and ubiquitin, exhibiting ubiquitination-promoting activity.
- This activity requires pVHL to bind elongin C and Cul-2, components related to SCF E3 ligase complexes.
- Tumor-derived pVHL mutants show a loss of ubiquitination-promoting activity.
Conclusions:
- pVHL is identified as a component of a potential SCF-like E3 ubiquitin-protein ligase complex.
- This finding establishes a direct link between the pVHL tumor suppressor and the ubiquitination process.
- Dysregulation of pVHL-associated ubiquitination may contribute to kidney cancer development.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Abnormal Proliferation
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Hedgehog Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

